Cargando…
The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain
Mutations in the tyrosine phosphatase SHP2 are associated with a variety of human diseases, including cancer and developmental disorders. Most mutations in SHP2 increase its basal catalytic activity by disrupting auto-inhibitory interactions between its phosphatase domain and N-terminal SH2 (phospho...
Autores principales: | van Vlimmeren, Anne E., Voleti, Rashmi, Chartier, Cassandra A., Jiang, Ziyuan, Karandur, Deepti, Shah, Neel H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369915/ https://www.ncbi.nlm.nih.gov/pubmed/37502916 http://dx.doi.org/10.1101/2023.07.10.548257 |
Ejemplares similares
-
High-throughput profiling of sequence recognition by tyrosine kinases and SH2 domains using bacterial peptide display
por: Li, Allyson, et al.
Publicado: (2023) -
Determining folding and binding properties of the C‐terminal SH2 domain of SHP2
por: Nardella, Caterina, et al.
Publicado: (2021) -
Unveiling the Molecular Basis of the Noonan Syndrome-Causing Mutation T42A of SHP2
por: Toto, Angelo, et al.
Publicado: (2020) -
Rewiring the transcriptional regulatory circuits of cells
por: Scannell, Devin R, et al.
Publicado: (2004) -
Evolutionary rewiring of bacterial regulatory networks
por: Taylor, Tiffany B., et al.
Publicado: (2015)